Literature DB >> 9316448

Cell cycle regulation of membrane glucocorticoid receptor in CCRF-CEM human ALL cells: correlation to apoptosis.

F N Sackey1, C S Watson, B Gametchu.   

Abstract

The human leukemic cell line (CCRF-CEM) and a subline enriched for the plasma membrane-resident glucocorticoid receptor (mGR) were studied for the influence of the cell cycle on the expression and function of mGR. Three synchronization procedures (double thymidine, colcemid, and combined thymidine-colcemid blocks) were used. Fluorescent microscopy and flow cytometry simultaneously assessed antibody-tagged mGR and DNA. In addition, mGR was quantitated and characterized by immunoprecipitation and immunoblotting. Apoptosis was assayed by DNA fragmentation (TUNEL assay) and by cell survival (trypan blue exclusion). All synchronization procedures demonstrated that progression from DNA replication (S) to the second growth phase and mitosis (G2/M) leads to cells having the highest levels of mGR expression and being highly glucocorticoid sensitive in the apoptosis assays: 32 and 80% sensitivity of wild type and mGR-enriched cells, respectively, compared with 12 and 30% sensitivity in asynchronous cells. Therefore, mGR expression appears to be cell cycle regulated, with its highest expression at late S-G2/M, when the cells are most sensitive to the lymphocytolytic effects of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316448     DOI: 10.1152/ajpendo.1997.273.3.E571

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  High-sensitivity immunofluorescence staining: a comparison of the liposome procedure and the FASER technique on mGR detection.

Authors:  Cindy Strehl; Timo Gaber; Manuela Jakstadt; Martin Hahne; Paula Hoff; Cornelia M Spies; Alexander Scheffold; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  J Fluoresc       Date:  2013-02-14       Impact factor: 2.217

2.  Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathway.

Authors:  C M Spies; D H S Schaumann; T Berki; K Mayer; M Jakstadt; D Huscher; C Wunder; G-R Burmester; A Radbruch; R Lauster; A Scheffold; F Buttgereit
Journal:  Ann Rheum Dis       Date:  2006-01-31       Impact factor: 19.103

3.  Immunoaffinity isolation of native membrane glucocorticoid receptor from S-49++ lymphoma cells: biochemical characterization and interaction with Hsp 70 and Hsp 90.

Authors:  C E Powell; C S Watson; B Gametchu
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

4.  Dexamethasone induces the secretion of annexin I in immature lymphoblastic cells by a calcium-dependent mechanism.

Authors:  M Castro-Caldas; C B Duarte; A P Carvalho; M C Fernandes Lopes
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

Review 5.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

Review 6.  Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch.

Authors:  Renato Malcher-Lopes; Alier Franco; Jeffrey G Tasker
Journal:  Eur J Pharmacol       Date:  2008-01-31       Impact factor: 4.432

7.  Membrane glucocorticoid receptor activation induces proteomic changes aligning with classical glucocorticoid effects.

Authors:  Sara Vernocchi; Nadia Battello; Stephanie Schmitz; Dominique Revets; Anja M Billing; Jonathan D Turner; Claude P Muller
Journal:  Mol Cell Proteomics       Date:  2013-01-22       Impact factor: 5.911

8.  Non-genomic inhibitory effect of glucocorticoids on activated peripheral blood basophils through suppression of lipid raft formation.

Authors:  S Yamagata; K Tomita; H Sano; Y Itoh; Y Fukai; N Okimoto; N Watatani; S Inbe; H Miyajima; K Tsukamoto; H Santoh; H Ichihashi; A Sano; R Sato; Y Tohda
Journal:  Clin Exp Immunol       Date:  2012-10       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.